Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseasesNew data emphasizes the consistent benefit of Bylvay as an... | May 17, 2023

Related Keywords

Paris ,France General ,France ,Netherlands ,London ,City Of ,United Kingdom ,Germany ,Saclay ,Austria ,Groningen ,Cambridge ,Cambridgeshire ,Vienna ,Wien ,China ,United States ,Belgium ,Shanghai ,Italy ,American ,America ,Georg Friedrich Vogel ,Amy Wolf ,Anna Gibbins ,Nadia Ovchinsky ,Nicolas Bogler ,Intrahepatic Cholestasis ,Ipsen Euronext ,Richardj Thompson ,Mark Nomden ,Howard Mayer ,Asia Pacific ,Tassos Grammatikopoulos ,Ioana Piscociu ,Grossman School Of Medicine ,Institute Of Cell Biology ,University Medical Center Groningen ,Head Of Research ,Institute Of Liver ,University Of Innsbruck ,King College London ,Department Of Pediatrics ,Head Of Corporate Brand Strategy Communications ,Albireo Pharma Inc ,Department Of Paediatrics ,Department Of Pediatric Surgery ,University Of Groningen ,Global Head Of Franchise Communications ,Annual Meeting ,European Society ,Paediatric Gastroenterology ,Executive Vice President ,Alagille Syndrome ,Top Line Results ,Placebo Controlled Study ,Hassenfeld Children ,Plenary Session ,Highest Scoring ,Interim Results ,Parallel Session Hepatology ,Abstract Session ,Native Liver Survival ,Odevixibat Serum Bile Acid Responders ,Progressive Familial Intrahepatic Cholestasis ,Molecular Hepatology ,Liver Studies ,College London ,Responsive Patients ,Bile Export Pump Deficiency ,Pediatric Surgery ,Parallel Session ,Odevixibat Treatment ,Undefined Cholestasis ,Case Report ,Paper Poster ,Odevixibat Therapy After Liver Transplantation ,Severe Diarrhea ,Retrospective Case Series ,Cell Biology ,Medical University ,E Poster Presentations ,E Poster Station ,North America ,Middle East ,Reported Outcome ,Rare Disease ,Sponsored Leveli American Depositary Receipt ,Franchise Communications ,Corporate Brand Strategy ,Global Media ,Ipsen Stock Exchange ,News ,Information ,Press Release ,Six ,Abstracts ,O ,The ,Resented ,Emonstrating ,Efficacy ,End ,Tolerability ,F ,Investigational ,Bylvay ,N ,Elect ,Cholestatic ,Liver ,Iseasesnew ,Data ,Emphasizes ,He ,Consistent ,Benefit ,S Ipn Fr0010259150 ,